Barbra Streisand insists Melissa McCarthy Ozempic comment was ‘a compliment’

Bridesmaid actress Melissa McCarthy has responded to the stage and screen icon’s remark
Barbra Streisand (L) and Melissa McCarthy (R)
Getty
The Weekender

Sign up to our free weekly newsletter for exclusive competitions, offers and theatre ticket deals

I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice.

Barbra Streisand insisted that a comment about Ozempic aimed at actress Melissa McCarthy was a “compliment”.

Bridesmaids star McCarthy posted pictures on Instagram from the Center Theatre Group (CTG) gala, wearing a pastel green tulle dress with a matching blazer, alongside US director Adam Shankman in a baby pink suit.

Musical star, actress, writer and director Streisand left a comment on the post: “Give him my regards did you take Ozempic?” referencing the type two diabetes medicine acknowledged as effective for weight loss.

The comment, which was swiftly deleted, sparked furore online.

Addressing the backlash on her social media, Streisand told her 1.6 million followers: “I went on Instagram to see the photos we’d posted of the beautiful flowers I’d received for my birthday.

“Below them was a photo of my friend Melissa McCarthy, who I sang with on my Encore album.

“She looked fantastic! I just wanted to pay her a compliment. I forgot the world is reading!”

When asked about the comment in a video circulating online, 53-year-old McCarthy said: “I think Barbra is a treasure, and I love her.”

Streisand is one of a handful of performers to have achieved EGOT status, a term for a select group of stars who have received at least one Emmy, Grammy, Oscar, or Tony award during their career.

Her comments come after Oprah Winfrey starred in an ABC special titled Shame, Blame, And The Weight Loss Revolution.

The special focused on weight-loss medication, which the TV host had previously admitted to taking, although has not specified which medication.

Ozempic can only be prescribed for patients with type two diabetes and is not licensed as a weight-loss drug in the UK or the US, although the UK government acknowledges: “It is not authorised for weight-loss, but it is used off-label for that purpose.”

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Sign up you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy notice .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in